Suppr超能文献

使用[125I]UdR释放法检测三种可移植性小鼠肿瘤中的细胞丢失和标记宿主细胞的流入情况。

Cell loss and influx of labeled host cells in three transplantable mouse tumors using [125I]UdR release.

作者信息

Franko A J, Kallman R F

出版信息

Cell Tissue Kinet. 1980 Jul;13(4):381-93. doi: 10.1111/j.1365-2184.1980.tb00477.x.

Abstract

The [125I]UdR loss technique was used to estimate cell loss from RIF-1, EMT6 and KHJJ tumors in order to determine the length of the delay between labeling and the beginning of the loss of labeled cells, and also to calculate a value for phi, the cell loss factor. To determine the importance of reutilization of label released from the gut and/or the influx of labeled host cells, the blood flow to some tumors was occluded during and for 30 min after injection of the label. Relatively small amounts of radioactivity entered occluded RIF-1 tumors during 9 days after injection of [125I]UdR, indicating that reutilization of systemic label and influx of labeled host cells are not significant in this system. In contrast, substantial amounts of radioactivity entered occluded EMT6 and KHJJ tumors, reaching 40% of the total activity in non-occluded tumors during 6 days following injection. After corrections were made for this influx of label, the [125I]UdR loss curves from RIF-1 and EMT6 tumors were essentially exponential from the first day following injection of label. This was interpreted as indicating the loss of proliferating as well as non-proliferating cells from both tumors. The cell loss factor derived from the [125I]UdR loss curves corrected for influx appeared to agree well with published values derived from analysis of percent labeled mitoses curves. In contrast, the corrected [125I]Udr loss curves from KHJJ tumors showed that loss of activity began three days after injection of label, indicating that primarily nonproliferating cells are lost from this tumor.

摘要

采用[125I]尿苷(UdR)损失技术来估计RIF-1、EMT6和KHJJ肿瘤中的细胞损失,以确定标记与标记细胞损失开始之间的延迟时间,并计算细胞损失因子φ的值。为了确定肠道释放的标记物再利用和/或标记宿主细胞流入的重要性,在注射标记物期间及之后30分钟,阻断了部分肿瘤的血流。注射[125I]UdR后9天内,相对少量的放射性进入血流被阻断的RIF-1肿瘤,这表明全身标记物的再利用和标记宿主细胞的流入在该系统中并不显著。相比之下,大量放射性进入血流被阻断的EMT6和KHJJ肿瘤,在注射后6天内达到未阻断肿瘤总活性的40%。对这种标记物流入进行校正后,RIF-1和EMT6肿瘤的[125I]UdR损失曲线从注射标记物后的第一天起基本呈指数形式。这被解释为表明这两种肿瘤中增殖细胞和非增殖细胞都有损失。经流入校正后的[125I]UdR损失曲线得出的细胞损失因子似乎与从标记有丝分裂百分比曲线分析得出的已发表值非常吻合。相比之下,KHJJ肿瘤经校正后的[125I]Udr损失曲线显示,标记物活性在注射后三天开始下降,这表明该肿瘤主要损失的是非增殖细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验